Publicacións en colaboración con investigadores/as de University of Manchester (20)

2007

  1. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis

    Arthritis Care and Research, Vol. 57, Núm. 1, pp. 125-132

  2. Lack of association between interleukin-6 promoter polymorphism at position -174 and Henoch-Schönlein purpura

    Clinical and Experimental Rheumatology, Vol. 25, Núm. 1 SUPPL. 44

2006

  1. Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis

    Clinical and Experimental Rheumatology, Vol. 24, Núm. 5, pp. 576-579

2005

  1. Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in Northwestern Spain

    Journal of Rheumatology, Vol. 32, Núm. 6, pp. 1081-1085

  2. Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis

    Journal of Rheumatology, Vol. 32, Núm. 1, pp. 74-76

2004

  1. E-selectin polymorphism in erythema nodosum secondary to sarcoidosis

    Clinical and Experimental Rheumatology, Vol. 22, Núm. 2, pp. 230-232

  2. Echocardiographic and Doppler Findings in Long-Term Treated Rheumatoid Arthritis Patients without Clinically Evident Cardiovascular Disease

    Seminars in Arthritis and Rheumatism, Vol. 33, Núm. 4, pp. 231-238

  3. Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-γ, increase susceptibility to giant cell arteritis

    Journal of Rheumatology, Vol. 31, Núm. 12, pp. 2413-2417

  4. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain

    Rheumatology, Vol. 43, Núm. 9, pp. 1182-1185

  5. Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica

    Clinical and Experimental Rheumatology, Vol. 22, Núm. 6 SUPPL.

  6. Interleukin 1β Gene Polymorphism Association with Severe Renal Manifestations and Renal Sequelae in Henoch-Schönlein Purpura

    Journal of Rheumatology, Vol. 31, Núm. 2, pp. 295-298

  7. Lack of Association between Endothelial Nitric Oxide Synthase Polymorphisms and Henoch-Schönlein Purpura

    Journal of Rheumatology, Vol. 31, Núm. 2, pp. 299-301

  8. Lack of Association between ICAM-1 Gene Polymorphisms and Biopsy-Proven Erythema Nodosum [5]

    Journal of Rheumatology

2003

  1. Corticotropin-releasing hormone promoter polymorphisms in patients with rheumatoid arthritis from Northwest Spain

    Journal of Rheumatology, Vol. 30, Núm. 5, pp. 913-917

  2. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica

    Seminars in Arthritis and Rheumatism, Vol. 33, Núm. 1, pp. 38-48

  3. HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis

    American Journal of Medicine, Vol. 114, Núm. 8, pp. 647-652

  4. Polymyalgia Rheumatica and Biopsy-Proven Giant Cell Arteritis Exhibit Different HLA-DRBI* Associations [5]

    Journal of Rheumatology

2000

  1. RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 18, Núm. 3, pp. 391-393

1999

  1. Can HLA-DR explain the varying frequency of synovitis in polymyalgia rheumatica? Comment on the article by Salvarani et al [6] (multiple letters)

    Arthritis and Rheumatism

1998

  1. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association

    Journal of Rheumatology, Vol. 25, Núm. 11, pp. 2140-2145